Literature DB >> 6954488

Inactivation of cap-binding proteins accompanies the shut-off of host protein synthesis by poliovirus.

K A Lee, N Sonenberg.   

Abstract

Infection of HeLa cells with poliovirus results in a rapid shut-off of host protein synthesis. It has been suggested that inactivation of a protein that binds to the cap structure of cellular mRNAs would explain the selective inhibition of host protein synthesis because the naturally uncapped poliovirus RNA can be translated by a cap-independent mechanism. To test directly for the presence of cap-binding proteins in poliovirus-infected and mock-infected cells, we analyzed initiation factor preparations for their ability to specifically crosslink to the 5' cap structure of oxidized reovirus mRNA. The data presented here show that the crosslinking ability of the different cap-binding proteins (24-, 28-, 32-, 50-, and 80-kilodalton polypeptides) is reduced in preparations from poliovirus-infected as compared to mock-infected cells. This reduction correlates with the inability of initiation factor preparations from infected cells to restore translation of capped mRNAs in extracts of poliovirus-infected cells. In addition, initiation factor preparations from poliovirus-infected cells have the ability to rapidly inactivate cap-binding proteins and can also impair the restoring activity of initiation factors from mock-infected cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954488      PMCID: PMC346437          DOI: 10.1073/pnas.79.11.3447

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Poliovirus proteins associated with ribosomal structures in infected cells.

Authors:  P J Wright; P D Cooper
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

2.  In vitro translation of cardiovirus ribonucleic acid by mammalian cell-free extracts.

Authors:  K L Eggen; A J Shatkin
Journal:  J Virol       Date:  1972-04       Impact factor: 5.103

3.  Initiation of mammalian protein synthesis: the importance of ribosome and initiation factor quality for the efficiency of in vitro systems.

Authors:  M H Schreier; T Staehelin
Journal:  J Mol Biol       Date:  1973-02-19       Impact factor: 5.469

4.  Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase.

Authors:  A K Banerjee; A J Shatkin
Journal:  J Virol       Date:  1970-07       Impact factor: 5.103

5.  5'-terminal structure of poliovirus polyribosomal RNA is pUp.

Authors:  M J Hewlett; J K Rose; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

6.  Structural difference between the 5' termini of viral and cellular mRNA in poliovirus-infected cells: possible basis for the inhibition of host protein synthesis.

Authors:  R Fernandez-Munoz; J E Darnell
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

7.  The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np.

Authors:  A Nomoto; Y F Lee; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

8.  Poliovirus-induced inhibition of polypeptide initiation in vitro on native polyribosomes.

Authors:  Y Kaufmann; E Goldstein; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

9.  Regulation of protein synthesis in HeLa cells. 3. Inhibition during poliovirus infection.

Authors:  R Leibowitz; S Penman
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

10.  Virus-induced interference in heterologously infected HeLa cells.

Authors:  M Doyle; J J Holland
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

View more
  45 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer.

Authors:  V Evdokimova; P Ruzanov; H Imataka; B Raught; Y Svitkin; L P Ovchinnikov; N Sonenberg
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

3.  The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure.

Authors:  Y V Svitkin; A Pause; A Haghighat; S Pyronnet; G Witherell; G J Belsham; N Sonenberg
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

4.  Localization of cap-binding protein in subcellular fractions of HeLa cells.

Authors:  J L Hansen; D O Etchison; J W Hershey; E Ehrenfeld
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

5.  Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.

Authors:  N Sonenberg; D Guertin; K A Lee
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

6.  Cowpea mosaic virus middle component RNA contains a sequence that allows internal binding of ribosomes and that requires eukaryotic initiation factor 4F for optimal translation.

Authors:  A A Thomas; E ter Haar; J Wellink; H O Voorma
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.

Authors:  C U Hellen; M Fäcke; H G Kräusslich; C K Lee; E Wimmer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein.

Authors:  T V Pestova; C U Hellen; E Wimmer
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Nucleotide sequences important for translation initiation of enterovirus RNA.

Authors:  N Iizuka; H Yonekawa; A Nomoto
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  mRNA discrimination in extracts from uninfected and reovirus-infected L-cells.

Authors:  R Lemieux; H Zarbl; S Millward
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.